Immunotherapies: an effective Leukemia treatment option In the challenging landscape of leukemia treatment, acute and chronic myelomonocytic leukemia (AML M4/5 and CMML) present hurdles, especially for older patients. With a scant two-year survival period, standard treatments pose risks, and effective immunotherapies for CMML/AML M4/5 are lacking. However,
Introducing iBlastoids Scientists have created iBlastoids, a cutting-edge in vitro model of human blastocysts that outperforms existing systems. These mini replicas accurately mimic the structure of natural blastocysts and can generate both pluripotent and trophoblast stem cells. What’s cool about them Not only do iBlastoids effectively model early implantation
Breakthrough Alert! Scientists craft a game-changing vaccine to halt lung cancer metastasis. Tiny but mighty nanoparticles zero in on a key protein, curbing cancer growth and spread. In mice, this vaccine slashed lung metastasis from breast and skin cancers, boosting survival rates post-surgery. Metastasis: the culprit In the relentless battle
Who found this? KAUST researchers have introduced an intriguing advancement known as PNP editing, an abbreviation for peptide nucleic acid (PNA) assisted prokaryotic Argonaute (pAgo) editing. This novel technique revolves around making highly precise modifications to specific segments of DNA. PNAs, these synthetic counterparts of DNA, possess a distinctive feature:
Researchers from the University of Rochester have undertaken a significant endeavor, introducing a specific gene associated with enhanced cellular repair and protection into mice. This pursuit holds promising implications for uncovering the intricacies of aging and potentially extending human lifespan. The basis of this investigation is the intriguing cancer resistance